Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration
- PMID: 25560730
- DOI: 10.7326/M14-0698
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration
Abstract
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. This explanation and elaboration document describes the rationale; clarifies the meaning of each item; and discusses why transparent reporting is important, with a view to assessing risk of bias and clinical usefulness of the prediction model. Each checklist item of the TRIPOD Statement is explained in detail and accompanied by published examples of good reporting. The document also provides a valuable reference of issues to consider when designing, conducting, and analyzing prediction model studies. To aid the editorial process and help peer reviewers and, ultimately, readers and systematic reviewers of prediction model studies, it is recommended that authors include a completed checklist in their submission. The TRIPOD checklist can also be downloaded from www.tripod-statement.org.
Similar articles
-
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.Eur J Clin Invest. 2015 Feb;45(2):204-14. doi: 10.1111/eci.12376. Epub 2015 Jan 5. Eur J Clin Invest. 2015. PMID: 25623047
-
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement.Eur Urol. 2015 Jun;67(6):1142-1151. doi: 10.1016/j.eururo.2014.11.025. Epub 2015 Jan 5. Eur Urol. 2015. PMID: 25572824
-
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697. Ann Intern Med. 2015. PMID: 25560714
-
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.BMJ. 2015 Jan 7;350:g7594. doi: 10.1136/bmj.g7594. BMJ. 2015. PMID: 25569120 Review.
-
Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.J Clin Epidemiol. 2015 Feb;68(2):134-43. doi: 10.1016/j.jclinepi.2014.11.010. J Clin Epidemiol. 2015. PMID: 25579640
Cited by
-
A multicenter prospective study on postoperative pulmonary complications prediction in geriatric patients with deep neural network model.Front Surg. 2022 Aug 9;9:976536. doi: 10.3389/fsurg.2022.976536. eCollection 2022. Front Surg. 2022. PMID: 36017511 Free PMC article.
-
Prognostic models versus single risk factor approach in first-trimester selective screening for gestational diabetes mellitus: a prospective population-based multicentre cohort study.BJOG. 2021 Mar;128(4):645-654. doi: 10.1111/1471-0528.16446. Epub 2020 Sep 1. BJOG. 2021. PMID: 32757408 Free PMC article. Clinical Trial.
-
Development and validation of a clinical prediction rule for development of diabetic foot ulceration: an analysis of data from five cohort studies.BMJ Open Diabetes Res Care. 2021 May;9(1):e002150. doi: 10.1136/bmjdrc-2021-002150. BMJ Open Diabetes Res Care. 2021. PMID: 34035053 Free PMC article.
-
Reporting of coronavirus disease 2019 prognostic models: the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis statement.Ann Transl Med. 2021 Mar;9(5):421. doi: 10.21037/atm-20-6933. Ann Transl Med. 2021. PMID: 33842642 Free PMC article. Review.
-
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study.J Immunother Cancer. 2024 Sep 3;12(9):e009348. doi: 10.1136/jitc-2024-009348. J Immunother Cancer. 2024. PMID: 39231545 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources